Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPRAGLIFLOZIN L-PROLINE vs IPTACOPAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPRAGLIFLOZIN L-PROLINE vs IPTACOPAN: Safety Overview

Metric IPRAGLIFLOZIN L-PROLINE IPTACOPAN
Total FAERS Reports 124 468
Deaths Reported 9 23
Death Rate 7.3% 4.9%
Hospitalizations 74 88
Average Patient Age 62.1 yrs 48.8 yrs
% Female Patients 37.6% 53.4%
FDA Approval Date N/A Dec 5, 2023
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription